Risk of Venous Thromboembolism in Glioblastoma Patients

Background Patients with cancer are at increased risk of venous thromboembolic events (VTE) with a particularly high prevalence in patients with glioblastoma (GB). We designed this current study to determine the incidence of symptomatic VTE in patients with GB undergoing first-line chemoradiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Gerald, Ho, Clement, Roldan Urgoti, Gloria, Leugner, Derek, Easaw, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059517/
https://www.ncbi.nlm.nih.gov/pubmed/30050733
http://dx.doi.org/10.7759/cureus.2678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059517/
https://www.ncbi.nlm.nih.gov/pubmed/30050733
http://dx.doi.org/10.7759/cureus.2678

Ejemplares similares